Xcell Biosciences Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$27.5M
- Investors
-
21
Xcell Biosciences General Information
Description
Developer of a bench-top primary cell control system designed to advance immunotherapy research and manufacturing, empowering scientists with better tools for cell maintenance, expansion, and control. The company's technology supports a range of primary cell types, including immune, stem, and tumor cells, enabling clients with predictive therapy development and improved clinical outcomes.
Contact Information
Website
www.xcellbio.comCorporate Office
- 455 Mission Bay Boulevard South
- Suite 124
- San Francisco, CA 94158
- United States
Corporate Office
- 455 Mission Bay Boulevard South
- Suite 124
- San Francisco, CA 94158
- United States
Xcell Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 17-Dec-2024 | $27.5M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series B) | 13-Sep-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 23-Feb-2017 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-May-2015 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Xcell Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Xcell Biosciences Comparisons
Industry
Financing
Details
Xcell Biosciences Competitors (8)
One of Xcell Biosciences’s 8 competitors is Sphere Fluidics, a Formerly VC-backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sphere Fluidics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| HiFiBiO Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Cytena | Formerly VC-backed | Freiburg, Germany | ||||
| Standard BioTools | Formerly VC-backed | Boston, MA |
Xcell Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Xcell Biosciences Patents
Xcell Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250263658-A1 | Cell populations adapted to a tumor microenvironment | Pending | 05-Apr-2022 | ||
| WO-2023196215-A1 | Cell populations adapted to a tumor microenvironment | Inactive | 05-Apr-2022 | ||
| EP-4103201-A1 | Gas and liquid flow regulation system for cell culture | Pending | 14-Feb-2020 | ||
| EP-4103201-A4 | Gas and liquid flow regulation system for cell culture | Pending | 14-Feb-2020 | ||
| GB-202213128-D0 | Gas and liquid flow regulation system for cell culture | Active | 14-Feb-2020 | C12M41/40 |
Xcell Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Xcell Biosciences Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Avego Management | PE/Buyout | Minority | ||
| Berkeley SkyDeck | Accelerator/Incubator | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Dynamk Capital | Venture Capital | Minority | ||
| Formic Ventures | Venture Capital | Minority |
Xcell Biosciences FAQs
-
When was Xcell Biosciences founded?
Xcell Biosciences was founded in 2012.
-
Where is Xcell Biosciences headquartered?
Xcell Biosciences is headquartered in San Francisco, CA.
-
What is the size of Xcell Biosciences?
Xcell Biosciences has 17 total employees.
-
What industry is Xcell Biosciences in?
Xcell Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is Xcell Biosciences a private or public company?
Xcell Biosciences is a Private company.
-
What is Xcell Biosciences’s current revenue?
The current revenue for Xcell Biosciences is .
-
How much funding has Xcell Biosciences raised over time?
Xcell Biosciences has raised $60.4M.
-
Who are Xcell Biosciences’s investors?
Avego Management, Berkeley SkyDeck, Casdin Capital, Dynamk Capital, and Formic Ventures are 5 of 21 investors who have invested in Xcell Biosciences.
-
Who are Xcell Biosciences’s competitors?
Sphere Fluidics, HiFiBiO Therapeutics, Oxford Nanopore Technologies, Cytena, and Standard BioTools are some of the 8 competitors of Xcell Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
